Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
Digital medicines, which span chronic conditions, mental health issues such as depression, anxiety, and addiction, is just one of the topics that will be offered at MedCity INVEST PharmaTech, a virtual conference scheduled for July 26. Learn how to take part or register today.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.